These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16613400)

  • 1. EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advanced cancer?
    Groenvold M; Petersen MA; Aaronson NK; Arraras JI; Blazeby JM; Bottomley A; Fayers PM; de Graeff A; Hammerlid E; Kaasa S; Sprangers MA; Bjorner JB
    Palliat Med; 2006 Mar; 20(2):59-61. PubMed ID: 16613400
    [No Abstract]   [Full Text] [Related]  

  • 2. EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advanced cancer?
    Echteld MA; Deliens L; Onwuteaka-Philipsen B; Klein M; van der Wal G
    Palliat Med; 2006 Jan; 20(1):1-2. PubMed ID: 16482751
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
    Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
    Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quality of life of Brazilian patients in palliative care: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 PAL (EORTC QLQ-C15-PAL).
    Nunes NA
    Support Care Cancer; 2014 Jun; 22(6):1595-600. PubMed ID: 24463615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30.
    Lam K; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Poon M; Chow E
    J Palliat Med; 2013 Apr; 16(4):402-8. PubMed ID: 23458649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which symptoms and problems do advanced cancer patients admitted to specialized palliative care report in addition to those included in the EORTC QLQ-C15-PAL? A register-based national study.
    Rojas-Concha L; Hansen MB; Petersen MA; Groenvold M
    Support Care Cancer; 2020 Apr; 28(4):1725-1735. PubMed ID: 31297593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent Validation of the Japanese Version of the EORTC QLQ-C15-PAL for Patients With Advanced Cancer.
    Miyashita M; Wada M; Morita T; Ishida M; Onishi H; Sasaki Y; Narabayashi M; Wada T; Matsubara M; Takigawa C; Shinjo T; Suga A; Inoue S; Ikenaga M; Kohara H; Tsuneto S; Shima Y
    J Pain Symptom Manage; 2015 May; 49(5):953-9. PubMed ID: 25593101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the EORTC QLQ-C15-PAL and the FACIT-Pal for assessment of quality of life in patients with advanced cancer.
    Lien K; Zeng L; Nguyen J; Cramarossa G; Culleton S; Caissie A; Lutz S; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):541-7. PubMed ID: 21958099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer.
    Lee YJ; Suh SY; Choi YS; Shim JY; Seo AR; Choi SE; Ahn HY; Yim E
    Support Care Cancer; 2014 Jul; 22(7):1941-8. PubMed ID: 24577883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three shortened questionnaires for assessment of quality of life in advanced cancer.
    Chiu L; Chiu N; Chow E; Cella D; Beaumont JL; Lam H; Popovic M; Bedard G; Poon M; Wong E; Zeng L; Bottomley A
    J Palliat Med; 2014 Aug; 17(8):918-23. PubMed ID: 24922521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Mexican-Spanish version of the EORTC QLQ-C15-PAL questionnaire for the evaluation of health-related quality of life in patients on palliative care.
    Suárez-del-Real Y; Allende-Pérez S; Alférez-Mancera A; Rodríguez RB; Jiménez-Toxtle S; Mohar A; Oñate-Ocaña LF
    Psychooncology; 2011 Aug; 20(8):889-96. PubMed ID: 20662106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Thresholds for Clinical Importance of the EORTC QLQ-C15-PAL in Patients Receiving Palliative Treatment.
    Pilz MJ; Aaronson NK; Arraras JI; Caocci G; Efficace F; Groenvold M; Holzner B; van Leeuwen M; Loth FLC; Petersen MA; Ramage J; Tomaszewski KA; Young T; Giesinger JM
    J Palliat Med; 2021 Mar; 24(3):397-404. PubMed ID: 32835601
    [No Abstract]   [Full Text] [Related]  

  • 13. Minimal important differences in the EORTC QLQ-C15-PAL to determine meaningful change in palliative advanced cancer patients.
    Bedard G; Zeng L; Zhang L; Lauzon N; Holden L; Tsao M; Danjoux C; Barnes E; Sahgal A; Poon M; Hicks K; Chow E
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e38-46. PubMed ID: 23551493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care.
    Groenvold M; Petersen MA; Aaronson NK; Arraras JI; Blazeby JM; Bottomley A; Fayers PM; de Graeff A; Hammerlid E; Kaasa S; Sprangers MA; Bjorner JB;
    Eur J Cancer; 2006 Jan; 42(1):55-64. PubMed ID: 16162404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
    Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Patient Self-Reported Quality of Life and Health Care Professional-Assessed Symptoms in Terminally ill Patients With Cancer.
    Matsumura C; Koyama N; Sako M; Kurosawa H; Nomura T; Eguchi Y; Ohba K; Yano Y
    Am J Hosp Palliat Care; 2021 Mar; 38(3):283-290. PubMed ID: 32705893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of EORTC QLQ-C15-PAL scores and inflammatory biomarkers in predicting survival in terminally ill patients with cancer.
    Koyama N; Matsumura C; Shitashimizu Y; Sako M; Kurosawa H; Nomura T; Eguchi Y; Ohba K; Yano Y
    BMC Cancer; 2021 Mar; 21(1):304. PubMed ID: 33757453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between sex, age and spiritual well-being scores on the EORTC QLQ-SWB32 for patients receiving palliative care for cancer: A further analysis of data from an international validation study.
    Rohde GE; Young T; Winstanley J; Arraras JI; Black K; Boyle F; Bredart A; Costantini A; Guo J; Irarrazaval ME; Kobayashi K; Kruizinga R; Navarro M; Omidvari S; Serpentini S; Spry N; van Laarhoven H; Yang G; Vivat B
    Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13145. PubMed ID: 31433533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors.
    Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S
    Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life and satisfaction with care among palliative cancer patients in Saudi Arabia.
    Aboshaiqah A; Al-Saedi TS; Abu-Al-Ruyhaylah MM; Aloufi AA; Alharbi MO; Alharbi SS; Al-Saedi AS; Al-Erwi AF
    Palliat Support Care; 2016 Dec; 14(6):621-627. PubMed ID: 27323905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.